Cryoprecipitate
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Overview
Cryoprecipitate is a blood product prepared from plasma. Each 15 mL unit contains about 100 U of factor VIII, 250* mg of fibrinogen, von Willebrand factor, factor XIII, and fibronectin.
- NOTE: – Standards state that there has to be a minimum of 150 mg of fibrinogen per bag of cryo, however most bags have around 250 mg (the number used in many calculations).
– There has to be a minimum of 80 IU of factor VIII.
Indications for giving cryoprecipitate include:
- Haemophilia– Used for emergency back up when factor concentrates are not available.
- von Willebrands’s disease
- hypofibrinogenaemia (low fibrinogen levels), as can occur with massive transfusions
- bleeding from excessive anticoagulation– Plasma contains most of the coagulation factors, and is a much better choice when anticoagulation has to be quickly reversed.
- massive haemorrhage– RBCs and volume expanders are much better choices for this.
- disseminated intravascular coagulation
References
References
- Erber WN, Perry DJ (2006) Plasma and plasma products in the treatment of massive haemorrhage. Best Pract Res Clin Haematol 19(1):97-112. PMID 16377544
Looking for the patient version?
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH
